🇺🇸 FDA
Pipeline program

Stimus (NNG-DEPO)

NNG06.2

Phase 3 mab completed

Quick answer

Stimus (NNG-DEPO) for Anemia is a Phase 3 program (mab) at Biotech Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).

Program details

Company
Biotech Pharmaceutical Co.,
Indication
Anemia
Phase
Phase 3
Modality
mab
Status
completed

Clinical trials